The largest database of trusted experimental protocols

Wst 1 viability assay

Manufactured by Roche
Sourced in Germany

The WST-1 viability assay is a colorimetric assay that measures cell proliferation and viability. It is based on the cleavage of the tetrazolium salt WST-1 to a colored formazan product by mitochondrial dehydrogenases in viable cells. The amount of formazan produced is directly proportional to the number of metabolically active cells in the sample, providing a quantitative measure of cell viability.

Automatically generated - may contain errors

5 protocols using wst 1 viability assay

1

Cytotoxicity Evaluation of Chemotherapeutics

Check if the same lab product or an alternative is used in the 5 most similar protocols
CCa cells (2.0 × 104/well) were seeded in a 96-well plate. 24 h later, the culture medium was removed and cells were treated with a range of concentrations of oxaliplatin, paclitaxel, and vincristine as indicated for another 48 h. Subsequent cell viability was determined using the WST-1 viability assay (Roche Applied Science, Mannheim, Germany) according to the manufacturer's protocol. The optical density was measured at 450 nm with 650 nm as the reference wavelength with a microplate reader (xMark™ Microplate, Bio-Rad, Hercules, CA, USA). Based on the drug response curves, we determined the IC50 values (drug concentrations that achieved 50% growth inhibition) in respect to the different drug treatments using Bliss method [21 (link)]. Evaluation of cell apoptosis was carried out using an apoptosis ELISA kit (Roche Diagnostics, Shanghai, China), as per the manufacturer's instructions.
+ Open protocol
+ Expand
2

WST-1 Cytotoxicity Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
D11-mediated cytotoxicity was determined by the WST-1 viability assay (Roche, Hvidovre, Denmark). Viability was quantified in a microtiter plate reader (VersaMax ELISA, Molecular Devices, Sunnyvale, CA, USA) after adding the WST-1 reagent to the cells according to the manufacturer’s guidelines.
+ Open protocol
+ Expand
3

Evaluating the Impact of ML246 on Ovarian Cancer Cell Viability and Invasion

Check if the same lab product or an alternative is used in the 5 most similar protocols
SKOV3 and OVCAR3 cells were treated with vehicle or ML246 for 72 h at the indicated concentrations. Cell viability was measured using the WST-1 viability assay as per the manufacturer’s instructions (Roche, Switzerland).
In vitro invasion assays were performed on SKOV3 and OVCAR3 using 24-well transwell units with polycarbonate filters (pore size: 8 μm) coated on the upper side with reconstituted basement membrane matrix, Matrigel (BD Biosciences, USA). 5 × 105 cells were added to the transwell in serum free media. Media with FBS was added to the outer compartment as the chemoattractant. Cells were treated with DMSO or ML246, and cultured for 72 h at 37 °C. Cells remaining on the upper side of the transwell were scraped off with a cotton swab. Cells remaining on the underside of the membrane were fixed and stained using the commercially available, Shandon Kwik-Diff stain kit (ThermoFisher Scientific). Cells were counted in four fields and the mean + SEM was calculated. This experiment was performed in triplicate in three independent experiments.
+ Open protocol
+ Expand
4

Immunotoxin Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a concentration of 1.5×104 cells/well into 96-well plates. After overnight incubation, cells were treated with SO1861 for 15 min followed by addition of immunotoxin. After 48 h, cell viability was determined with help of the WST-1 viability assay (Roche Diagnostics, Mannheim, Germany) according to the manufacturer’s instructions. Quantification of apoptotic and necrotic cells after treatment was analyzed using the Apoptosis and Necrosis Quantification Kit Plus, according to the manufacturer’s protocol (Biotium, Fremont, CA, United States).
+ Open protocol
+ Expand
5

Viability Assay for MK-1775 and BMN673 Combination

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following the addition of (0.1, 0.5, 1 and 10 MK-1775 and BMN673 and their combinations), for 24, 48 and 72 h, the viability, i.e., the estimation of remaining live healthy cells in response to therapy of the cell population was estimated using WST-1 viability assay (Roche Diagnostics GmbH) as previously described in more detail (47 (link),48 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!